3111 New Hyde Park Road,
Lake Success, NY 11042
Caregiver’s Information
Vishesh Agrawal, MD
Associate Clinical Director
Office Locations
Background
Dr. Vishesh Agrawal is a distinguished radiation oncologist at Advanced Radiation Centers of New York (ARC), practicing at the Lake Success office in Nassau County. He earned his medical degree from Harvard Medical School and medical internship at Brigham and Women’s Hospital, followed by radiation oncology residency at New York-Presbyterian Hospital, Weill Cornell Medical Center.
Throughout his training, Dr. Agrawal received several honors, including the ASTRO Resident Recognition Award, the Silverman Fellowship in Healthcare Innovation, and the Cornell Distinguished Housestaff Award in Radiation Oncology. His research has been published in prestigious medical journals, contributing to advancements in the care of patients with prostate cancer and other malignancies.
Dr. Agrawal is committed to providing compassionate, patient-centered care, utilizing the latest advancements in radiation therapy to achieve optimal outcomes for his patients.
Education & Training
BA: University of Pennsylvania, Philadelphia, PA (Biochemistry and Biology), 2011. Summa cum laude.
MD: Harvard Medical School, Boston, MA, 2016. Magna cum laude.
Medical Intern: Brigham and Women’s Hospital, Boston, MA, 2016-2017
Residency: NewYork-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, 2017-2021Awards and Honors
ASTRO Resident Recognition Award – 2020
Silverman Fellowship in Healthcare Innovation – 2020
Distinguished Housestaff Award (Radiation Oncology) – 2019
Neysa Cristol Adams Prize in Biology – 2011Publications
Agrawal V, Ma X, Hu J, Barbieri C, Nagar H. (2021). Active Surveillance for Men with Intermediate Risk Prostate Cancer. J Urol. 205(1):115-121. PubMed PMID: 32658588.
Agrawal V, Ma X, Hu J, Barbieri C, Nagar H. (2020). Trends and Disparities in the Initial Management of High-Risk Prostate Cancer in the United States. JAMA Netw Open. 3(8):e2014674. PubMed PMID: 32865572.
Agrawal V, Ko EC. (2020). Radiotherapy and Immunotherapy Combinations for Lung Cancer. Current Oncology Reports. 23(1):4. PubMed PMID: 33215306.
Agrawal V, Ma X, Hu J, Barbieri C, Nagar H. Trends in Androgen Deprivation Use in Men with Intermediate Risk Prostate Cancer Who Underwent Radiotherapy. Submitted.
Agrawal V, Alshak M, Eidelberg A, Nagar H, Margolis D, Babich J, Formenti SC, Kang J. (2020). Phase I Trial of MRI Guided Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost for Localized Prostate Cancer. Submitted.
Agrawal V, Fecteau R, Alshak M, Eidelberg A, Nagar H, Kang J. (2020). Interfraction Prostate Volume During MRI-guided Prostate Stereotactic Body Radiation Therapy: Impact on Treatment Delivery and Implications. Manuscript in preparation.
Kamran SC, Coroller T, Milani N, Agrawal V, Baldini EH, Chen AB, Johnson BE, Kozono D, Franco I, Chopra N, Zeleznik R, Aerts HJWL, Mak R. (2020). The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer. Radiation Oncology. 5(1):14. PubMed PMID: 31937336
Agrawal V, Ng J. “Esophageal Cancer.” Radiation Oncology Management Decisions. Philadelphia: Wolters Kluwer, 2019.
Agrawal V, Coroller TP, Hou Y, Lee SW, Romano JL, Baldini EH, Chen AB, Kozono D, Swanson SJ, Wee JO, Aerts HJWL, Mak RH. (2017). Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC. PLoS One. 12(4):e0174268. PubMed PMID: 28426673
Huynh E, Coroller TP, Narayan V, Agrawal V, Romano J, Franco I, Parmar C, Hou Y, Mak RH, Aerts HJ. (2017). Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT. PLoS One. 12(1):e0169172. PubMed PMID: 28046060
Franco I, Chen YH, Chipidza F, Agrawal V, Romano J, Baldini E, Chen A, Colson Y, Hou Y, Kozono D, Wee J, Mak R. (2017). Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. J Geriatr Oncol. 2017. S1879-4068(17)30183-2. PubMed PMID: 28941581
Coroller TP, Agrawal V, Huynh E, Narayan V, Lee SW, Mak RH, Aerts HJ. (2017). Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC. J Thorac Oncol. 12(3):467-476. PubMed PMID: 27903462
Hou Y, Lee SW, Agrawal V, Romano J, Baldini EH, Chen AB, Kozono DE, Killoran JH, Wagar M, Hacker FL, Aerts HJ, Lewis JH, Mak RH.. Inter-scan and inter-observer tumor volume variability on cone beam computed tomography (CBCT) in patients treated with stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC). (2017). J Med Imaging Radiat Oncol. 61(1):93-98. PubMed PMID: 27709803
Agrawal V, Coroller TP, Hou Y, Lee SW, Romano JL, Baldini EH, Chen AB, Jackman DM, Kozono D, Swanson SJ, Wee JO, Aerts HJ, Mak RH. (2016). Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC. Lung Cancer. 102:1-8. PubMed PMID: 27987576
Coroller TP, Agrawal V, Narayan V, Hou Y, Grossmann P, Lee SW, Mak RH, Aerts HJ. (2016). Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol. 119(3):480-6. PubMed PMID: 27085484
Agrawal V, Marcoux JP, Rabin M, Vernowsky I, Wee JO, Mak R. Case Report of Primary Tracheal Squamous Cell Carcinoma Treated with Radiotherapy and Concurrent Chemotherapy. (2016). Advances in Radiation Oncology. 1(2): 127-31. PubMed PMID: 28740880
Huynh E, Coroller TP, Narayan V, Agrawal V, Hou Y, Romano J, Franco I, Mak RH, Aerts HJ. (2016). CTbased radiomic analysis of stereotactic body radiation therapy patients with lung cancer. Radiother Oncol. 120(2):258-66. PubMed PMID: 27296412
Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, Saad A, Li MK, Hughes MR et al. (2015). Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nature Communications. 6:8715. PubMed PMID: 26493500
Liu JC, Guan X, Ryan JA, Rivera AG, Mock C, Agrawal V, Letai A, Lerou PH, Lahav G. (2013). High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. Cell Stem Cell. 13(4):483-91. PubMed PMID: 23954752
Glineburg MR, Chavez A, Agrawal V, Brill SJ, Johnson FB. (2013) Resolution by unassisted Top3 points to template switch recombination intermediates during DNA replication. J Biol Chem. 15;288(46):33193-204. PubMed PMID: 24100144
Chavez A, Agrawal V, Johnson FB. (2011). Homologous recombination-dependent rescue of deficiency in the structural maintenance of chromosomes (Smc) 5/6 complex. J Biol Chem. 286(7):5119-25. PubMed PMID: 21138837
Chavez A, George V, Agrawal V, Johnson FB. (2010). Sumoylation and the structural maintenance of chromosomes (Smc) 5/6 complex slow senescence through recombination intermediate resolution. J Biol Chem. 285(16):11922-30. PubMed PMID: 20159973
Oral Presentations
Agrawal V, Hissourou M, Fenton-Kerimian MB, Sa S, Brandmaier A, Ye JC, Golden EB, Kang J, Ng J, Chang EL, and Formenti SC. Prone Accelerated Partial Breast Irradiation Comparing Five versus Three Fractions for Early Stage Breast Cancer: A Multi-Institutional Prospective Randomized Trial. Presented at ASTRO Annual Meeting, Quick Pitch, 2020.
Poster Presentations
Agrawal V, Kaylor K, Fenton-Kerimian MB, Golden EB, Kang J, Ng J, and Formenti SC. Feasibility of Hypofractionated Radiation Therapy to the Breast and Nodal Stations after Neo-Adjuvant Systemic Therapy and Surgery (NCT02917421). Presented at ASTRO Annual Meeting, 2020
Agrawal V, Farjam R, Nagar H, Margolis D, Babich J, Formenti SC, Kang J. Real-time MRI-guided Prostate Stereotactic Body Radiation Therapy: Impact on Treatment Delivery and Implications. Presented at ASTRO Annual Meeting, Chicago, IL, 2019.
Agrawal V, Ma X, Kang J, Nagar H. Delayed Radiation Therapy is Associated with Improved Overall Survival in Node Positive Prostate Cancer. Presented at ASTRO Annual Meeting, San Antonio, TX, 2018.
Agrawal V, Coroller TP, Hou Y, Lee SW, Aerts HJWL, Mak RH. Mediastinal Lymph Node Volume is Associated with Locoregional Recurrence and Overall Survival in Stage IIIA-IIIB NSCLC. Presented at ASTRO Annual Meeting, Boston, MA, 2016.
Research Experience
Clinical Research Assistant – Investigating non-small cell lung cancer response to therapy using CT based radiomics. Dana Farber Cancer Institute and Brigham and Women’s Hospital, Dept. of Radiation Oncology, Dr. Raymond Mak and Dr. Hugo Aerts, Boston, MA. October 2014 to November 2015 Harvard-MIT HST Research Assistantship – Analysis of DNA damage in naïve and primed induced pluripotent cells. Harvard School of Medicine and Brigham and Women’s Hospital, Dept. of Genetics, Lerou Lab, Boston, MA. January 2012 to February 2013.
Testimonials